SGLT-2 inhibitors are the first medication class ever to have beneficial effects in patients with HFmrEF and HFpEF. The benefits are mainly driven by a decrease in HF hospitalizations.
This article presents two sisters with focal atrial arrhythmias originating from the right and left interatrial septum. The diagnosis of Lamin A/C mutation was made years after the intervention.